Alcon licenses anti-infective compound

Article

Fort Worth, TX-Alcon Laboratories' affiliate Alcon Manufacturing Ltd. has signed a collaboration and licensing agreement with NovaCal Pharmaceuticals to research, develop, and commercialize NovaCal's novel Aganocide topical compounds to treat bacterial, viral, and fungal infections in the eye, ear, and sinus.

Fort Worth, TX-Alcon Laboratories' affiliate Alcon Manufacturing Ltd. has signed a collaboration and licensing agreement with NovaCal Pharmaceuticals to research, develop, and commercialize NovaCal's novel Aganocide topical compounds to treat bacterial, viral, and fungal infections in the eye, ear, and sinus.

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.